BLUEPRINT MEDICINES CORP shareholders Q2 2023

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.

BLUEPRINT MEDICINES CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 448,987$28,375,97815.72%
DAFNA Capital Management LLC 251,521$15,896,1274.35%
Casdin Capital, LLC 620,000$39,184,0003.42%
Rock Springs Capital Management LP 2,186,672$138,197,6703.29%
EcoR1 Capital, LLC 1,798,300$113,652,5602.78%
Novo Holdings A/S 448,804$28,364,4132.19%
ORACLE INVESTMENT MANAGEMENT INC 41,377$2,615,0261.93%
SECTORAL ASSET MANAGEMENT INC 136,837$8,648,0981.44%
EMERALD MUTUAL FUND ADVISERS TRUST 413,327$26,122,2661.42%
EMERALD ADVISERS, LLC 496,053$31,350,5501.37%
EFG Asset Management (North America) Corp. 90,124$5,693,1331.22%
Avidity Partners Management LP 415,000$26,228,0000.92%
NBW CAPITAL LLC 52,540$3,320,5280.78%
Capital Impact Advisors, LLC 10,676$674,7230.74%
Hood River Capital Management LLC 273,449$17,282,0000.51%
Eventide Asset Management 438,500$27,713,2000.47%
Granahan Investment Management 184,503$11,660,5900.36%
HARBOR CAPITAL ADVISORS, INC. 24,353$1,539,1100.31%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1,474,490$93,187,7680.30%
TORRAY INVESTMENT PARTNERS LLC 23,740$1,500,3680.26%
External links

This page lists BLUEPRINT MEDICINES CORP's shareholders in Q2 2023. To view BLUEPRINT MEDICINES CORP's shareholder history, click here.